Prevalence Estimate Chlamydia And gonorrhoea Netherlands, second editio

Completed

• Conditions: Gonorroe; Sexually Transmitted Infections (STI); 10008555

• Registration Number: NL-OMON51506
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-03-31
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1149

Inclusion Criteria

Age 16.5-34 years and sexually active

Exclusion Criteria

age below 16.5 years or above 34 years; no sexual experience (no experience
with vaginal or anal intercourse)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Proportion chlamydia and gonorrhoea positive among participants and estimates<br /><br>thereof for the entire population and by risk factor / subgroup<br /><br>(or combinations thereof).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- To evaluate the validity of current surveillance data, by getting better<br /><br>insight into the prevalence and risk factors among the population groups<br /><br>visiting the general practice or STI clinic for STI testing and those who do<br /><br>not seek STI Healthcare (but have been at risk for STI).<br /><br>- Gain better insight into the factors (demographic and behavioral) associated<br /><br>with STIs in the Netherlands.<br /><br>- To obtain data that can serve as input for transmission models in the<br /><br>Netherlands to predict the impact of interventions.<br /><br>- To obtain insights in changes over time of the STI prevalence by comparing<br /><br>the results from this study with the results of the previous edition of PECAN<br /><br>(2017). </p><br>